Warsaw, Indiana, March 6, 2018 - WishBone Medical. Inc. entered into a U.S. distribution agreement with Implanet to distribute the JAZZ implant system to treat spinal pathologies requiring vertebral fusion surgery in the Orthopedic Market.
The first procedure with WishBone Medical surgeons was completed in early 2018. “We are looking forward to expanding our Orthopedic spine products and the JAZZ system is our first product in this market,” said Nick Deeter, Chairman of the Board and CEO at WishBone Medical.
Mr. Deeter added, “WishBone Medical provides innovative implants and instruments in sterile packed, single use disposable kits and the JAZZ implant system is available in these single use kits.”
Ludovic Lastennet, CEO of Implanet said, “This disruptive single use, sterile packed business model of WishBone Medical compliments the Implanet America JAZZ platform of single use, sterile packed products.”
To learn more about WishBone Medical, visit www.WishBoneMedical.com
About WishBone Medical, Inc.
WishBone Medical is a Global pediatric orthopedic company, committed to providing anatomically appropriate innovative implants and instruments in sterile packed, single use, disposable kits, to prevent infection, reduce overall costs for our customers and achieve the best outcomes for children around the world who are still growing.
For further information, visit www.WishBoneMedical.com or call Andrew Miclot, Vice-Chairman and President at 574-306-4006.
Founded in 2007, IMPLANET is a medical technology company that manufactures high-quality implants for orthopedic surgery. Its flagship product, the JAZZ® latest-generation implant, aims to treat spinal pathologies requiring vertebral fusion surgery. Protected by four families of international patents, JAZZ® has obtained 510(k) regulatory clearance from the Food and Drug Administration (FDA) in the United States and the CE mark. IMPLANET employs 48 staff and recorded 2017 sales of €7.8 million. For further information, please visit www.implanet.com.
Based near Bordeaux in France, IMPLANET established a US subsidiary in Boston in 2013.
IMPLANET is listed on Euronext™ Growth market in Paris. ALIMP
To learn more about IMPLANET, visit www.Implanet.com